Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06793098 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Functional Proteins in Polycystic Ovary Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 1, 2026 to Dec 1, 2027
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v3
  2. Study title expanded, about 2 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The concentration of functional proteins: kisspeptin, ghrelin, zonulin will be measured and compared in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), in women with PCOS without IR, and in women without PCOS.
Trial Details
NCT Number NCT06793098
Lead Sponsor Jagiellonian University
Conditions
(from sponsor)		 Reproductive Age, PCOS (Polycystic Ovary Syndrome)
Related terms Insulin Resistance, Metabolic Syndrome, Polycystic Ovary Syndrome
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov